SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device
Washington D.C., Dec. 18, 2020 — The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO,...